ω-3 Fatty Acids Ethyl Esters Suppress Cerebral Vasospasm and Improve Clinical Outcome Following Aneurysmal Subarachnoid Hemorrhage.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  World Neurosurgery

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.wneu.2016.12.018PMID 27993744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study.

  2014cited by this paper
• Pharmacological evidence showing significant roles for potassium channels and CYP epoxygenase metabolites in the relaxant effects of docosahexaenoic acid on the rat aorta contracted with U46619.

  2014cited by this paper
• Pharmacological Characteristics of the Inhibitory Effects of Docosahexaenoic Acid on Vascular Contractions Studied in Rat Mesenteric Artery

  2014cited by this paper
• Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.

  2013cited by this paper
• Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta

  2013cited by this paper
• Early Inhibition of Natriuresis Suppresses Symptomatic Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage

  2013cited by this paper
• Effect of Clazosentan in Patients with Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials

  2012cited by this paper
• Docosahexaenoic Acid Signaling Modulates Cell Survival in Experimental Ischemic Stroke Penumbra and Initiates Long-Term Repair in Young and Aged Rats

  2012cited by this paper
• Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

  2010cited by this paper
• [Increased urinary sodium excretion in the early phase of aneurysmal subarachnoid hemorrhage as a predictor of cerebral salt wasting syndrome].

  2009cited by this paper
• Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

  2009cited by this paper
• Protective effect of docosahexaenoic acid against brain injury in ischemic rats.

  2009cited by this paper
• Cholesterol Primes Vascular Smooth Muscle to Induce Ca2+ Sensitization Mediated by a Sphingosylphosphorylcholine–Rho-Kinase Pathway: Possible Role for Membrane Raft

  2006cited by this paper
• Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.

  2006cited by this paper
• Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

  2005cited by this paper
• Fish Consumption and Incidence of Stroke: A Meta-Analysis of Cohort Studies

  2004cited by this paper
• Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.

  2003cited by this paper
• Involvement of Src Family Protein Tyrosine Kinases in Ca2+ Sensitization of Coronary Artery Contraction Mediated by a Sphingosylphosphorylcholine-Rho-Kinase Pathway

  2002cited by this paper
• Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: Evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution

  2002cited by this paper
• Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.

  2000cited by this paper
• Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm.

  2000cited by this paper
• A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

  1995cited by this paper
• Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.

  1992cited by this paper
• Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.

  1989cited by this paper
• Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

  1980cited by this paper
• Timing and perioperative care in intracranial aneurysm surgery.

  1974cited by this paper

• Spinal Drainage and Combined Pharmacotherapy as Potential Strategies to Improve Outcomes for Patients with Poor-Grade Subarachnoid Hemorrhage Treated with Clipping or Coiling but Not Receiving Nimodipine

  2025cites this paper
• Potential for multidrug combination therapy in patients with World Federation of Neurological Surgeons grade V subarachnoid hemorrhage

  2025cites this paper
• The polyunsaturated fatty acid and oxylipin plasma signature of aneurysmal subarachnoid haemorrhage, case-control study

  2025cites this paper
• Mitochondrial health and redox imbalance in the context of learning and memory in post-subarachnoid haemorrhage: therapeutic strategies for recovery.

  2025cites this paper
• Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia

  2024cites this paper
• Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage

  2024cites this paper
• Omega-3 polyunsaturated fatty acids alleviate endoplasmic reticulum stress-induced neuroinflammation by protecting against traumatic spinal cord injury through the histone deacetylase 3/ peroxisome proliferator-activated receptor-γ coactivator pathway.

  2024cites this paper
• Intracranial Aneurysms and Lipid Metabolism Disorders: From Molecular Mechanisms to Clinical Implications

  2023cites this paper
• Marine-derived n-3 fatty acids therapy for stroke.

  2022cites this paper
• Effectiveness comparisons of drug therapies for postoperative aneurysmal subarachnoid hemorrhage patients: network meta‑analysis and systematic review

  2021cites this paper
• The Efficacy of Omega-3 Fatty Acid Supplementation for Improving Health Outcomes in Patients With Neurological Injuries and Traumas

  2021cites this paper
• Nutrition in the Neurocritical Care Unit: a New Frontier

  2021cites this paper
• Effect of Omega-3 Polyunsaturated Fatty Acids in Modulation of Vascular Tone under Physiological and Pathological Conditions.

  2020cites this paper
• Computed tomography perfusion imaging after aneurysmal subarachnoid hemorrhage can detect cerebral vasospasm and predict delayed cerebral ischemia after endovascular treatment

  2020cites this paper
• Aneurysmal Subarachnoid Hemorrhage and Resolution of Inflammation

  2019cites this paper
• Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage

  2019cites this paper
• Marine-derived n-3 fatty acids therapy for stroke.

  2019cites this paper
• Public health relevance of drug–nutrition interactions

  2017cites this paper
• Marine‐derived n‐3 fatty acids therapy for stroke

  2017cites this paper
• Urinary F2-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage.

  2017cites this paper
• Long-chain omega-3 fatty acids in aneurysmal subarachnoid hemorrhage: A randomized pilot trial of pharmaconutrition

  2017cites this paper